BIIB BIOGEN INC Earnings Reports 8-K Filing 2024 - Earnings Report Biogen Inc. reported a quarterly earnings loss of $1.1 billion, with a revenue decrease of 24% compared to the previous year, primarily due to declining sales of its multiple sclerosis treatments.Get access to all SEC 8-K filings of the BIOGEN INC